Valuation: Avantor, Inc.

Market Cap 7.05B 6.16B 5.66B 5.28B 10.01B 671B 10.16B 67.96B 26.42B 330B 26.45B 25.88B 1,136B P/E 2026 *
28.7x
P/E 2027 * 23.9x
Enterprise Value 10.06B 8.79B 8.08B 7.53B 14.29B 958B 14.5B 97.01B 37.71B 471B 37.75B 36.94B 1,622B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.42x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 70 01/01/2026
Director/Board Member 62 01/10/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 7.05B
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.68%+4.67%+6.30%+0.29% 59.87B
Weighted average by Cap. +3.28%+3.80%-3.84%+1.05%

Financials

2026 *2027 *
Net sales 6.5B 5.68B 5.22B 4.87B 9.24B 619B 9.38B 62.71B 24.38B 304B 24.41B 23.88B 1,049B 6.64B 5.8B 5.33B 4.97B 9.43B 632B 9.57B 64.03B 24.89B 311B 24.92B 24.39B 1,071B
Net income 244M 213M 196M 183M 346M 23.22B 352M 2.35B 914M 11.41B 915M 896M 39.33B 289M 253M 232M 216M 410M 27.52B 417M 2.79B 1.08B 13.53B 1.08B 1.06B 46.61B
Net Debt 3.01B 2.63B 2.42B 2.26B 4.28B 287B 4.34B 29.05B 11.29B 141B 11.31B 11.06B 486B 2.36B 2.07B 1.9B 1.77B 3.36B 225B 3.41B 22.78B 8.86B 111B 8.87B 8.68B 381B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-